control igg igg2a isotype control clone 2a3 antibody (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
90
Structured Review
Bio X Cell
control igg igg2a isotype control clone 2a3 antibody
Control Igg Igg2a Isotype Control Clone 2a3 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/isotype+control+igg+antibody+clone+2a3/anti+cd4+gk1+5/pm37525015-265-16-24
Average 90 stars, based on 1 article reviews
Control Igg Igg2a Isotype Control Clone 2a3 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/isotype+control+igg+antibody+clone+2a3/anti+cd4+gk1+5/pm37525015-265-16-24
Average 90 stars, based on 1 article reviews
control igg igg2a isotype control clone 2a3 antibody - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Control:Article Title: Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity. Article Snippet: .. When the average MC38 tumor volume reached 80 to 120 mm3, mice were randomized into different groups and were treated with anti- PD- 1 (a- PD1) (clone 29F.1A12, BE0273, Bio X Cell) or Article Title: Monitoring Response to Combinatorial Immunotherapies by Tracking both T Cells and Natural Killer Cells In Vivo via ImmunoPET-Raman Multimodal Gold Nanostars Article Snippet: .. Control mice received façade treatment of 120 μg Article Title: H3K27ac-induced IFITM3 promotes progression of TNBC and resistance to anti-PD-1/PD-L1 therapy via the TNF-α/NF-κB/PD-L1 axis. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant with limited effective targeted therapies, leading to poor patient outcomes.. Although immune checkpoint inhibitors (ICIs) have shown promise in cancer treatment, most patients with TNBC exhibit primary or secondary resistance to ICIs, restricting their clinical use.. Interferoninduced transmembrane protein 3 (IFITM3), an interferon-induced protein, is highly overexpressed in various tumors and is associated with immune suppression; however, its role in TNBC progression and immune escape remains unclear. Article Title: Hydroxyapatite microspheres induce durable pleurodesis and are rapidly cleared by pleural osteoclasts Article Snippet: .. C57BL/6J mice were treated with i.p. anti-mouse RANKL mAb (Bio-X-Cell, catalog BE0191, clone IK 22-5) or a Article Title: AR + TREM2 + macrophage induced pathogenic immunosuppression promotes prostate cancer progression Article Snippet: Mice receiving enzalutamide (MedChemExpress, MCE, HY-70002) treatment (30 mg/kg) were orally administrated five times per week, and the untreated group received the control solvent DMSO. .. Mice receiving anti-PD1 (Clone RMP1-14, BE0146, BioXcell) treatment (200 μg per mouse) were intraperitoneally administrated every 3 days, and the untreated group received the Article Title: Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma Article Snippet: .. Mice received three cycles of antibodies against PD1 (Cat# BE0146, clone RMP114, 300 μg/mouse; BioXCell, Lebanon, NH) and CTLA4 (Cat# BE0131, clone 9H10, 200 μg/mouse, BioXCell) or matched Article Title: Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma Article Snippet: .. Mice received three cycles of antibodies against PD1 (Cat# BE0146, clone RMP1-14, 300 μg/mouse; BioXCell, Lebanon, NH) and CTLA4 (Cat# BE0131, clone 9H10, 200 μg/mouse, BioXCell) or matched Mouse Assay:Article Title: AR + TREM2 + macrophage induced pathogenic immunosuppression promotes prostate cancer progression Article Snippet: Mice receiving enzalutamide (MedChemExpress, MCE, HY-70002) treatment (30 mg/kg) were orally administrated five times per week, and the untreated group received the control solvent DMSO. .. Mice receiving anti-PD1 (Clone RMP1-14, BE0146, BioXcell) treatment (200 μg per mouse) were intraperitoneally administrated every 3 days, and the untreated group received the Article Title: Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma Article Snippet: .. Mice received three cycles of antibodies against PD1 (Cat# BE0146, clone RMP114, 300 μg/mouse; BioXCell, Lebanon, NH) and CTLA4 (Cat# BE0131, clone 9H10, 200 μg/mouse, BioXCell) or matched Article Title: Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma Article Snippet: .. Mice received three cycles of antibodies against PD1 (Cat# BE0146, clone RMP1-14, 300 μg/mouse; BioXCell, Lebanon, NH) and CTLA4 (Cat# BE0131, clone 9H10, 200 μg/mouse, BioXCell) or matched |